Indeed, our results support the hypothesis that the anti-tumor effect is more dependent upon differences in cytokine secretion between CD4+ and CD8+ cells rather than relative differences in tumor-infiltrating lymphocyte density (Fig. 3). The gene discussed is CD8A; the disease is neoplasm.